Tixagevimab–cilgavimab for treatment of patients hospitalised with COVID-19: a randomised, double-blind, phase 3 trialClinical Trial Published on 2022-07-082022-10-05 Journal: The Lancet. Respiratory Medicine [Category] [DOI] 10.1016/S2213-2600(22)00215-6 [Article Type] Clinical Trial
Efficacy and safety of a single dose of casirivimab and imdevimab for the prevention of COVID-19 over an 8-month period: a randomised, double-blind, placebo-controlled trialRandomized Controlled Trial Published on 2022-07-052022-10-05 Journal: The Lancet. Infectious Diseases [Category] [DOI] 10.1016/S1473-3099(22)00416-9 [Article Type] Randomized Controlled Trial
Evaluation of antibody titer kinetics and SARS-CoV-2 infections in a large cohort of healthcare professionals ten months after administration of the BNT162b2 vaccineBNT162b2 백신 투여 10개월 후 대규모 의료 전문가 집단에서 항체 역가 동역학 및 SARS-CoV-2 감염 평가Multicenter Study Published on 2022-07-012022-09-11 Journal: Journal of Immunological Methods [Category] [DOI] 10.1016/j.jim.2022.113293 PMC 바로가기 [Article Type] Multicenter Study
SARS-CoV-2 during pregnancy and associated outcomes: Results from an ongoing prospective cohort임신 중 SARS-CoV-2 및 관련 결과: 진행중인 예상 코호트의 결과Article Published on 2022-07-012022-09-12 Journal: Paediatric and perinatal epidemiology [Category] [DOI] 10.1111/ppe.12812 PMC 바로가기 [Article Type] Article
Humoral Response to the Third Dose of Sars-Cov-2 Vaccine in Kidney Transplant RecipientsArticle Published on 2022-07-012022-11-15 Journal: Transplantation proceedings [Category] [DOI] 10.1016/j.transproceed.2022.02.011 PMC 바로가기
Absence of SARS-CoV-2 RNA and anti-SARS-CoV-2 antibodies in stray cats길 잃은 고양이에서 SARS-CoV-2 RNA 및 항-SARS-CoV-2 항체의 부재Article Published on 2022-07-012022-09-11 Journal: Transboundary and emerging diseases [Category] [DOI] 10.1111/tbed.14200 PMC 바로가기 [Article Type] Article
An Analysis of Serological Response and Infection Outcomes Following Oxford-AstraZeneca (AZD1222) and Pfizer-BioNTech (mRNA BNT162b2) SARS-CoV-2 Vaccines in Kidney and Kidney-pancreas Transplants신장 및 신장-췌장 이식에서 Oxford-AstraZeneca(AZD1222) 및 Pfizer-BioNTech(mRNA BNT162b2) SARS-CoV-2 백신에 따른 혈청학적 반응 및 감염 결과 분석Article Published on 2022-07-012022-09-12 Journal: Transplantation [Category] [DOI] 10.1097/TP.0000000000004105 PMC 바로가기 [Article Type] Article
Neutralizing COVID-19 Convalescent Plasma in Adults Hospitalized With COVID-19: A Blinded, Randomized, Placebo-Controlled TrialRandomized Controlled Trial Published on 2022-07-012022-10-05 Journal: Chest [Category] [DOI] 10.1016/j.chest.2022.06.029 [Article Type] Randomized Controlled Trial
Variant of Concern-Matched COVID-19 Convalescent Plasma Usage in Seronegative Hospitalized Patients혈청 음성 입원 환자에서 우려 일치 COVID-19 회복기 혈장 사용의 변형Article Published on 2022-06-302022-09-11 Journal: Viruses [Category] [DOI] 10.3390/v14071443 PMC 바로가기 [Article Type] Article
Robust antibody response after a third BNT162b2 vaccine compared to the second among immunocompromised and healthy individuals, a prospective longitudinal cohort studyBNT162b2 3차 백신 접종 후 면역 저하 및 건강한 2차 백신 대비 강력한 항체 반응, 전향적 종단 코호트 연구Observational Study Published on 2022-06-262022-09-12 Journal: Vaccine [Category] [DOI] 10.1016/j.vaccine.2022.05.051 PMC 바로가기 [Article Type] Observational Study